Evidence map›Paper›PMID 40903749›Full record

ArticleBasic and clinical andrology2025

Ureaplasma parvum impaired semen quality improves after doxycycline treatment in selected patients: a cohort study.

Harm-Henning Lindhof, Bernhard Homey

Abstract read
In one paragraph

Article in Basic and clinical andrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Harm-Henning LindhofDepartment of Dermatology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstrasse 5, 40225, Duesseldorf, Germany. Harm-Henning.Lindhof@med.uni-duesseldorf.de.
Bernhard HomeyDepartment of Dermatology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Moorenstrasse 5, 40225, Duesseldorf, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfections of the urogenital tract are recognized as potential contributors to male subfertility or infertility. Ureaplasma parvum is frequently detected in semen samples, yet its specific impact on semen quality and the potential benefit of antibiotic treatment remain uncertain.

resultsIn a retrospective cohort of 3,464 semen samples collected for fertility evaluation, Ureaplasma parvum was identified in 12.4% of cases using a multiplex PCR assay. Semen volume was significantly lower in infected individuals compared to uninfected controls. However, no significant differences were observed in sperm concentration, motility, morphology, or inflammatory markers. Among 124 men with documented pathogen eradication and follow-up semen analysis, doxycycline treatment led to a significant increase in sperm concentration (4.01 ± 4.69 to 9.20 ± 15.63 million/ml, p = 0.01) and motility (18.97 ± 16.04% to 29.66 ± 22.18%, p = 0.002). Peroxidase-positive leukocytes declined (1.84 ± 0.74 to 0.68 ± 0.79 million/ml, p = 0.005). In contrast, no significant changes were observed in men with normal baseline semen parameters.

conclusionThe mere detection of Ureaplasma parvum does not appear to compromise semen quality and may not warrant routine antibiotic treatment. Nevertheless, in Ureaplasma parvum-positive patients with abnormal semen parameters and elevated inflammatory markers, targeted antibiotic therapy may improve sperm quality. These findings support a selective treatment strategy, emphasizing clinical context and inflammatory status rather than routine screening or treatment of all infected individuals.

Indexed as

DoxycyclineFertilityInfectionSemenUreaplasma

Identifiers

PMID40903749
PMCPMC12409938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.